Corrias A, Dolci C, Adamo M C, Rossi G, Puggioni R, Burrai P
Pediatr Med Chir. 1982 Sep-Oct;4(5):515-7.
We tested a new product containing aminophylline with 1,56% alcohol as therapy of bronchospasm in childhood to evaluate therapeutic activity, tolerance and adverse reactions. Authors confirm the usefulness of this product in childhood but dosage must be individualized with monitoring of theophylline blood levels.
我们测试了一种含1.56%酒精的氨茶碱新产品,用于治疗儿童支气管痉挛,以评估其治疗活性、耐受性和不良反应。作者证实该产品对儿童有用,但用药剂量必须个体化,并监测茶碱血药浓度。